Table 2.
Cell information
Patient | Route of injection | Cell count (×106) | Cell viability (%) | Bacteriology | Mycoplasma | Endotoxin level (EU/ml) | Karyotype |
---|---|---|---|---|---|---|---|
1 | IV | 95 | 100 | NC | NC | <0.125 | 46XY |
2 | IV | 125 | 98 | NC | NC | <0.125 | 46XY |
3 | IV | 75 | 92.80 | NC | NC | <0.125 | 46XX |
4 | IV | 111 | 94 | NC | NC | <0.125 | 46XX |
5 | IV | 89 | 93 | NC | NC | <0.125 | 46XX |
7 | IT | 113 | 99.50 | NC | NC | <0.125 | 46XY |
8 | IT | 102 | 94 | NC | NC | <0.125 | 46XY |
9 | IT | 100 | 98 | NC | NC | <0.125 | 46XY |
10 | IT | 135 | 97 | NC | NC | <0.125 | 46XX |
11 | IT | 140 | 96 | NC | NC | <0.125 | 46XY |
12 | IT | 100 | 96 | NC | NC | <0.125 | 46XY |
13 | IT | 120 | 98 | NC | NC | <0.125 | 46XY |
IV; Intravenous, IT; Intrathecal, NC; No contamination, and EU; Endotoxin unit.